The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data.
Kate Taylor
PSI Conference Chair
Scientific Meetings
2019 PSI Annual Conference
Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London SW1P 3EE
The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data.
Kate Taylor
PSI Conference Chair
Training Courses
2019 PSI Annual Conference
Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London SW1P 3EE
The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data.
Kate Taylor
PSI Conference Chair
Journal Club
2019 PSI Annual Conference
Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London SW1P 3EE
The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data.
Kate Taylor
PSI Conference Chair
Webinars
2019 PSI Annual Conference
Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London SW1P 3EE
The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data.
Kate Taylor
PSI Conference Chair
Careers Meetings
2019 PSI Annual Conference
Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London SW1P 3EE
The theme for the PSI Conference 2019 was“Data Driven Decision Making in Medical Research”. The 2019 PSI Conference took place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with an optional half day training course on the Sunday afternoon.
Sessions included early phase innovative trial design, industry best practice - 10 years on, statistical issues in safety drug labelling, model based dose finding designs, an update from Transcelerate and much more, with speakers from industry, academia and regulatory agencies.
We welcomed abstracts on any subject but were interested in the following topics; decision making, bayesian topics within early or late phase, causal inference, future trends, pre-clinical statistics, patient reported outcomes, and patient-centric data.
Kate Taylor
PSI Conference Chair
Upcoming Events
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK